Subsequent Kaplan-Meier (K-M) survival analysis illustrated that patients with higher KIF2C expression suffered a worse OS and DFS, in addition to poorer tumor differentiation and higher relapse risk [107]. This evidence concerns the gene KIF2C and neoplasm.